{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:02:49Z","timestamp":1788577369062,"version":"build-2803163510"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1038\/s41380-025-03241-4","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T15:20:44Z","timestamp":1758640844000},"page":"1293-1310","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The alpha7 nicotinic acetylcholine receptor mediates network dysfunction in a mouse model of local amyloid pathology"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1378-4863","authenticated-orcid":false,"given":"Fani","family":"Koukouli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Lazarevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Rooy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4221-7526","authenticated-orcid":false,"given":"Boris","family":"Lamotte d\u2019Incamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Gaspar Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Pons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6814-9747","authenticated-orcid":false,"given":"J\u00e9r\u00e9my","family":"Peixoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Thiberge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifigeneia","family":"Nikolakopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Changeux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Bacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris S.","family":"Gutkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5328-9704","authenticated-orcid":false,"given":"Christoph","family":"Schmidt-Hieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2029-1437","authenticated-orcid":false,"given":"Uwe","family":"Maskos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"key":"3241_CR1","unstructured":"Patterson C World alzheimer report 2018. The state of the art of dementia research: New Frontiers; 2018. https:\/\/www.alzint.org\/resource\/world-alzheimer-report-2018\/."},{"key":"3241_CR2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","volume":"217","author":"RT Bartus","year":"1982","unstructured":"Bartus RT, Dean RL, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science. 1982;217:408\u201314.","journal-title":"Science"},{"key":"3241_CR3","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","volume":"2","author":"P Davies","year":"1976","unstructured":"Davies P, Maloney A. Selective loss of central cholinergic neurons in Alzheimer\u2019s disease. Lancet. 1976;2:1403.","journal-title":"Lancet"},{"key":"3241_CR4","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.7058341","volume":"215","author":"PJ Whitehouse","year":"1982","unstructured":"Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR. Alzheimer\u2019s disease and senile dementia: loss of neurons in the basal forebrain. Science. 1982;215:1237\u20139.","journal-title":"Science"},{"key":"3241_CR5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.psych.48.1.649","volume":"48","author":"BJ Everitt","year":"1997","unstructured":"Everitt BJ, Robbins TW. Central cholinergic systems and cognition. Annu Rev Psychol. 1997;48:649\u201384.","journal-title":"Annu Rev Psychol"},{"key":"3241_CR6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0166-2236(98)01361-7","volume":"22","author":"E Perry","year":"1999","unstructured":"Perry E, Walker M, Grace J, Perry R. Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends Neurosci. 1999;22:273\u201380.","journal-title":"Trends Neurosci"},{"key":"3241_CR7","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.cell.2020.01.024","volume":"180","author":"M Suzuki","year":"2020","unstructured":"Suzuki M, Larkum ME. General anesthesia decouples cortical pyramidal neurons. Cell. 2020;180:666\u201376.e13.","journal-title":"Cell"},{"key":"3241_CR8","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/j.cub.2018.05.025","volume":"28","author":"D Pal","year":"2018","unstructured":"Pal D, Dean JG, Liu T, Li D, Watson CJ, Hudetz AG, et al. Differential role of prefrontal and parietal cortices in controlling level of consciousness. Curr Biol. 2018;28:2145\u201352.e5.","journal-title":"Curr Biol"},{"key":"3241_CR9","doi-asserted-by":"crossref","first-page":"14823","DOI":"10.1073\/pnas.1614417113","volume":"113","author":"F Koukouli","year":"2016","unstructured":"Koukouli F, Rooy M, Changeux J-P, Maskos U. Nicotinic receptors in mouse prefrontal cortex modulate ultraslow fluctuations related to conscious processing. Proc Natl Acad Sci. 2016;113:14823\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"3241_CR10","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.tins.2020.06.001","volume":"43","author":"F Koukouli","year":"2020","unstructured":"Koukouli F, Changeux JP. Do nicotinic receptors modulate high-order cognitive processing? Trends Neurosci. 2020;43:550\u201364.","journal-title":"Trends Neurosci"},{"key":"3241_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005593","author":"J Birks","year":"2006","unstructured":"Birks J. Cholinesterase inhibitors for Alzheimer\u2019s disease. Cochrane Database Syst Rev. 2006. https:\/\/doi.org\/10.1002\/14651858.CD005593.","journal-title":"Cochrane Database Syst Rev"},{"key":"3241_CR12","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","volume":"141","author":"H Hampel","year":"2018","unstructured":"Hampel H, Mesulam M-M, Cuello AC, Farlow MR, Giacobini E, Grossberg GT, et al. The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease. Brain. 2018;141:1917\u201333.","journal-title":"Brain"},{"key":"3241_CR13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med. 2016;8:595\u2013608.","journal-title":"EMBO Mol Med"},{"key":"3241_CR14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell. 2019;179:312\u201339.","journal-title":"Cell"},{"key":"3241_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-021-00557-x","author":"KY Liu","year":"2021","unstructured":"Liu KY, Howard R. Can we learn lessons from the FDA\u2019s approval of aducanumab? Nat Rev Neurol. 2021. https:\/\/doi.org\/10.1038\/s41582-021-00557-x.","journal-title":"Nat Rev Neurol"},{"key":"3241_CR16","unstructured":"Alzheimer_Association. Aducanumab discontinued as an Alzheimer\u2019s treatment. https:\/\/www.alz.org\/alzheimers-dementia\/treatments\/aducanumab:2024."},{"key":"3241_CR17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388:9\u201321.","journal-title":"N Engl J Med"},{"key":"3241_CR18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0006-8993(86)90819-X","volume":"371","author":"P Whitehouse","year":"1986","unstructured":"Whitehouse P, Martino A, Antuono P, Lowenstein P, Coyle J, Price D, et al. Nicotinic acetylcholine binding sites in Alzheimer\u2019s disease. Brain Res. 1986;371:146\u201351.","journal-title":"Brain Res"},{"key":"3241_CR19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0304-3940(86)90629-4","volume":"72","author":"A Nordberg","year":"1986","unstructured":"Nordberg A, Winblad B. Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains. Neurosci Lett. 1986;72:115\u201320.","journal-title":"Neurosci Lett"},{"key":"3241_CR20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00213-006-0447-7","volume":"188","author":"A Kadir","year":"2006","unstructured":"Kadir A, Almkvist O, Wall A, L\u00e5ngstr\u00f6m B, Nordberg A. PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer\u2019s disease. Psychopharmacology. 2006;188:509\u201320.","journal-title":"Psychopharmacology"},{"key":"3241_CR21","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1093\/brain\/awy099","volume":"141","author":"O Sabri","year":"2018","unstructured":"Sabri O, Meyer PM, Gr\u00e4f S, Hesse S, Wilke S, Becker GA, et al. Cognitive correlates of \u03b14\u03b22 nicotinic acetylcholine receptors in mild Alzheimer\u2019s dementia. Brain. 2018;141:1840\u201354.","journal-title":"Brain"},{"key":"3241_CR22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neuropharm.2014.11.018","volume":"96","author":"S Lombardo","year":"2015","unstructured":"Lombardo S, Maskos U. Role of the nicotinic acetylcholine receptor in Alzheimer\u2019s disease pathology and treatment. Neuropharmacology. 2015;96:255\u201362.","journal-title":"Neuropharmacology"},{"key":"3241_CR23","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1523\/JNEUROSCI.18-12-04461.1998","volume":"18","author":"M Zoli","year":"1998","unstructured":"Zoli M, Lena C, Picciotto MR, Changeux JP. Identification of four classes of brain nicotinic receptors using beta2 mutant mice. J Neurosci. 1998;18:4461\u201372.","journal-title":"J Neurosci"},{"key":"3241_CR24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/374065a0","volume":"374","author":"MR Picciotto","year":"1995","unstructured":"Picciotto MR, Zoli M, Lena C, Bessis A, Lallemand Y, Le Novere N, et al. Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature. 1995;374:65\u20137.","journal-title":"Nature"},{"key":"3241_CR25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1523\/JNEUROSCI.0876-20.2020","volume":"41","author":"AA George","year":"2021","unstructured":"George AA, Vieira JM, Xavier-Jackson C, Gee MT, Cirrito JR, Bimonte-Nelson HA, et al. Implications of oligomeric amyloid-beta (oA\u03b242) signaling through \u03b17\u03b22-nicotinic acetylcholine receptors (nAChRs) on basal forebrain cholinergic neuronal intrinsic excitability and cognitive decline. J Neurosci. 2021;41:555\u201375.","journal-title":"J Neurosci"},{"key":"3241_CR26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev.pharmtox.40.1.431","volume":"40","author":"PJ Corringer","year":"2000","unstructured":"Corringer PJ, Le Novere N, Changeux JP. Nicotinic receptors at the amino acid level. Annu Rev Pharmacol Toxicol. 2000;40:431\u201358.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3241_CR27","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.bcp.2011.06.039","volume":"82","author":"HR Parri","year":"2011","unstructured":"Parri HR, Hernandez CM, Dineley KT. Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer\u2019s disease. Biochem Pharmacol. 2011;82:931\u201342.","journal-title":"Biochem Pharmacol"},{"key":"3241_CR28","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1046\/j.1471-4159.2000.0751155.x","volume":"75","author":"HY Wang","year":"2000","unstructured":"Wang HY, Lee DH, Davis CB, Shank RP. Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors. J Neurochem. 2000;75:1155\u201361.","journal-title":"J Neurochem"},{"key":"3241_CR29","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1111\/bph.14688","volume":"176","author":"E Cecon","year":"2019","unstructured":"Cecon E, Dam J, Luka M, Gautier C, Chollet AM, Delagrange P, et al. Quantitative assessment of oligomeric amyloid \u03b2 peptide binding to \u03b1 7 nicotinic receptor. Br J Pharmacol. 2019;176:3475\u201388.","journal-title":"Br J Pharmacol"},{"key":"3241_CR30","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.bcp.2015.07.018","volume":"97","author":"F Koukouli","year":"2015","unstructured":"Koukouli F, Maskos U. The multiple roles of the \u03b17 nicotinic acetylcholine receptor in modulating glutamatergic systems in the normal and diseased nervous system. Biochem Pharmacol. 2015;97:378\u201387.","journal-title":"Biochem Pharmacol"},{"key":"3241_CR31","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1074\/jbc.275.8.5626","volume":"275","author":"H-Y Wang","year":"2000","unstructured":"Wang H-Y, Lee DHS, D\u2019Andrea MR, Peterson PA, Shank RP, Reitz AB. \u03b2-Amyloid1\u201342 binds to \u03b17 nicotinic acetylcholine receptor with high affinity. J Biol Chem. 2000;275:5626\u201332.","journal-title":"J Biol Chem"},{"key":"3241_CR32","doi-asserted-by":"crossref","first-page":"8805","DOI":"10.1523\/JNEUROSCI.6159-08.2009","volume":"29","author":"G Dziewczapolski","year":"2009","unstructured":"Dziewczapolski G, Glogowski CM, Masliah E, Heinemann SF. Deletion of the {alpha}7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer\u2019s disease. J Neurosci. 2009;29:8805\u201315.","journal-title":"J Neurosci"},{"key":"3241_CR33","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1523\/JNEUROSCI.5038-09.2010","volume":"30","author":"CM Hernandez","year":"2010","unstructured":"Hernandez CM, Kayed R, Zheng H, Sweatt JD, Dineley KT. Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer\u2019s disease. J Neurosci. 2010;30:2442\u201353.","journal-title":"J Neurosci"},{"key":"3241_CR34","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/emboj\/18.5.1235","volume":"18","author":"M Zoli","year":"1999","unstructured":"Zoli M, Picciotto MR, Ferrari R, Cocchi D, Changeux J-P. Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors. EMBO J. 1999;18:1235\u201344.","journal-title":"EMBO J"},{"key":"3241_CR35","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.neuron.2023.11.014","volume":"112","author":"J Giorgio","year":"2023","unstructured":"Giorgio J, Adams JN, Maass A, Jagust WJ, Breakspear M. Amyloid induced hyperexcitability in default mode network drives medial temporal hyperactivity and early tau accumulation. Neuron. 2023;112:676\u201386.e4.","journal-title":"Neuron"},{"key":"3241_CR36","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/bies.201500004","volume":"37","author":"MA Busche","year":"2015","unstructured":"Busche MA, Konnerth A. Neuronal hyperactivity \u2013 a key defect in Alzheimer\u2019s disease. BioEssays. 2015;37:624\u201332.","journal-title":"BioEssays"},{"key":"3241_CR37","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.cortex.2020.08.015","volume":"132","author":"J Louren\u00e7o","year":"2020","unstructured":"Louren\u00e7o J, Koukouli F, Bacci A. Synaptic inhibition in the neocortex: orchestration and computation through canonical circuits and variations on the theme. Cortex. 2020;132:258\u201380.","journal-title":"Cortex"},{"key":"3241_CR38","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuron.2016.06.033","volume":"91","author":"R Tremblay","year":"2016","unstructured":"Tremblay R, Lee S, Rudy B. GABAergic interneurons in the neocortex: from cellular properties to circuits. Neuron. 2016;91:260\u201392.","journal-title":"Neuron"},{"key":"3241_CR39","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrn2188","volume":"8","author":"ZJ Huang","year":"2007","unstructured":"Huang ZJ, Di Cristo G, Ango F. Development of GABA innervation in the cerebral and cerebellar cortices. Nat Rev Neurosci. 2007;8:673\u201386.","journal-title":"Nat Rev Neurosci"},{"key":"3241_CR40","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nm.4274","volume":"23","author":"F Koukouli","year":"2017","unstructured":"Koukouli F, Rooy M, Tziotis D, Sailor KA, O\u2019Neill H, Levenga J, et al. Nicotine reverses hypofrontality in animal models of addiction and schizophrenia. Nat Med. 2017;23:347\u201354.","journal-title":"Nat Med"},{"key":"3241_CR41","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1523\/JNEUROSCI.19-13-05228.1999","volume":"19","author":"JT Porter","year":"1999","unstructured":"Porter JT, Cauli B, Tsuzuki K, Lambolez B, Rossier J, Audinat E. Selective excitation of subtypes of neocortical interneurons by nicotinic receptors. J Neurosci. 1999;19:5228\u201335.","journal-title":"J Neurosci"},{"key":"3241_CR42","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/cercor\/bhr390","volume":"23","author":"RB Poorthuis","year":"2013","unstructured":"Poorthuis RB, Bloem B, Schak B, Wester J, De Kock CPJ, Mansvelder HD. Layer-specific modulation of the prefrontal cortex by nicotinic acetylcholine receptors. Cereb Cortex. 2013;23:148\u201361.","journal-title":"Cereb Cortex"},{"key":"3241_CR43","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1126\/science.1134246","volume":"314","author":"Z Liu","year":"2006","unstructured":"Liu Z, Neff RA, Berg DK. Sequential interplay of nicotinic and GABAergic signaling guides neuronal development. Science. 2006;314:1610\u20133.","journal-title":"Science"},{"key":"3241_CR44","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.18632\/aging.101136","volume":"8","author":"F Koukouli","year":"2016","unstructured":"Koukouli F, Rooy M, Maskos U. Early and progressive deficit of neuronal activity patterns in a model of local amyloid pathology in mouse prefrontal cortex. Aging. 2016;8:3430\u201349.","journal-title":"Aging"},{"key":"3241_CR45","doi-asserted-by":"crossref","first-page":"e7280","DOI":"10.1371\/journal.pone.0007280","volume":"4","author":"T Jaworski","year":"2009","unstructured":"Jaworski T, Dewachter I, Lechat B, Croes S, Termont A, Demedts D, et al. AAV-tau mediates pyramidal neurodegeneration by cell-cycle re-entry without neurofibrillary tangle formation in wild-type mice. PLoS One. 2009;4:e7280.","journal-title":"PLoS One"},{"key":"3241_CR46","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.molimm.2008.09.008","volume":"46","author":"P Lafaye","year":"2009","unstructured":"Lafaye P, Achour I, England P, Duyckaerts C, Rougeon F. Single-domain antibodies recognize selectively small oligomeric forms of amyloid beta, prevent Abeta-induced neurotoxicity and inhibit fibril formation. Mol Immunol. 2009;46:695\u2013704.","journal-title":"Mol Immunol"},{"key":"3241_CR47","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1523\/JNEUROSCI.2177-05.2005","volume":"25","author":"RL Buckner","year":"2005","unstructured":"Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, et al. Molecular, structural, and functional characterization of Alzheimer\u2019s disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci. 2005;25:7709\u201317.","journal-title":"J Neurosci"},{"key":"3241_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncir.2017.00100","volume":"11","author":"J Obermayer","year":"2017","unstructured":"Obermayer J, Verhoog MB, Luchicchi A, Mansvelder HD. Cholinergic modulation of cortical microcircuits is layer-specific: evidence from rodent, monkey and human brain. Front Neural Circuits. 2017;11:1\u201312.","journal-title":"Front Neural Circuits"},{"key":"3241_CR49","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1523\/JNEUROSCI.5012-12.2013","volume":"33","author":"RB Poorthuis","year":"2013","unstructured":"Poorthuis RB, Bloem B, Verhoog MB, Mansvelder HD. Layer-specific interference with cholinergic signaling in the prefrontal cortex by smoking concentrations of nicotine. J Neurosci. 2013;33:4843\u201353.","journal-title":"J Neurosci"},{"key":"3241_CR50","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1126\/science.1162844","volume":"321","author":"MA Busche","year":"2008","unstructured":"Busche MA, Eichhoff G, Adelsberger H, Abramowski D, Wiederhold K-H, Haass C, et al. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer\u2019s disease. Science. 2008;321:1686\u20139.","journal-title":"Science"},{"key":"3241_CR51","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2022.119287","volume":"257","author":"AJ Albertson","year":"2022","unstructured":"Albertson AJ, Landsness EC, Tang MJ, Yan P, Miao H, Rosenthal ZP, et al. Normal aging in mice is associated with a global reduction in cortical spectral power and network-specific declines in functional connectivity. Neuroimage. 2022;257:119287.","journal-title":"Neuroimage"},{"key":"3241_CR52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1385\/JMN:27:1:013","volume":"27","author":"PW Lamb","year":"2005","unstructured":"Lamb PW, Melton MA, Yakel JL. Inhibition of neuronal nicotinic acetylcholine receptor channels expressed in xenopus oocytes by \u03b2-Amyloid1-42 peptide. J Mol Neurosci. 2005;27:13\u201322.","journal-title":"J Mol Neurosci"},{"key":"3241_CR53","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12031-011-9509-3","volume":"45","author":"A Pandya","year":"2011","unstructured":"Pandya A, Yakel JL. Allosteric modulator desformylflustrabromine relieves the inhibition of \u03b12\u03b22 and \u03b14\u03b22 nicotinic acetylcholine receptors by \u03b2-amyloid(1-42) peptide. J Mol Neurosci. 2011;45:42\u201347.","journal-title":"J Mol Neurosci"},{"key":"3241_CR54","doi-asserted-by":"crossref","first-page":"RC120","DOI":"10.1523\/JNEUROSCI.21-01-j0003.2001","volume":"21","author":"DL Pettit","year":"2001","unstructured":"Pettit DL, Shao Z, Yakel JL. \u03b2-Amyloid(1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice. J Neurosci. 2001;21:RC120.","journal-title":"J Neurosci"},{"key":"3241_CR55","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","volume":"55","author":"JJ Palop","year":"2007","unstructured":"Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer\u2019s disease. Neuron. 2007;55:697\u2013711.","journal-title":"Neuron"},{"key":"3241_CR56","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1126\/science.290.5498.1968","volume":"290","author":"JS Anderson","year":"2000","unstructured":"Anderson JS, Lampl I, Gillespie DC, Ferster D. The contribution of noise to contrast invariance of orientation tuning in cat visual cortex. Science. 2000;290:1968\u201372.","journal-title":"Science"},{"key":"3241_CR57","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1093\/brain\/awad250","volume":"146","author":"I Keramidis","year":"2023","unstructured":"Keramidis I, Mcallister BB, Bourbonnais J, Wang F, Isabel D, Rezaei E, et al. Restoring neuronal chloride extrusion reverses cognitive decline linked to Alzheimer\u2019s disease mutations. Brain. 2023;146:4903\u201315.","journal-title":"Brain"},{"key":"3241_CR58","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","volume":"89","author":"EX Albuquerque","year":"2009","unstructured":"Albuquerque EX, Pereira EFR, Alkondon M, Rogers SW. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev. 2009;89:73\u2013120.","journal-title":"Physiol Rev"},{"key":"3241_CR59","doi-asserted-by":"crossref","DOI":"10.1016\/j.crneur.2021.100018","volume":"2","author":"M Rooy","year":"2021","unstructured":"Rooy M, Lazarevich I, Koukouli F, Maskos U, Gutkin B. Cholinergic modulation of hierarchical inhibitory control over cortical resting state dynamics: local circuit modeling of schizophrenia-related hypofrontality. Curr Res Neurobiol. 2021;2:100018.","journal-title":"Curr Res Neurobiol"},{"key":"3241_CR60","doi-asserted-by":"crossref","first-page":"e1003183","DOI":"10.1371\/journal.pcbi.1003183","volume":"9","author":"M Graupner","year":"2013","unstructured":"Graupner M, Maex R, Gutkin B. Endogenous cholinergic inputs and local circuit mechanisms govern the phasic mesolimbic dopamine response to nicotine. PLoS Comput Biol. 2013;9:e1003183.","journal-title":"PLoS Comput Biol"},{"key":"3241_CR61","doi-asserted-by":"crossref","first-page":"8756","DOI":"10.1523\/JNEUROSCI.2645-08.2008","volume":"28","author":"SM Kassam","year":"2008","unstructured":"Kassam SM, Herman PM, Goodfellow NM, Alves NC, Lambe EK. Developmental excitation of corticothalamic neurons by nicotinic acetylcholine receptors. J Neurosci. 2008;28:8756\u201364.","journal-title":"J Neurosci"},{"key":"3241_CR62","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12826","volume":"7","author":"MB Verhoog","year":"2016","unstructured":"Verhoog MB, Obermayer J, Kortleven CA, Wilbers R, Wester J, Baayen JC, et al. Layer-specific cholinergic control of human and mouse cortical synaptic plasticity. Nat Commun. 2016;7:12826.","journal-title":"Nat Commun"},{"key":"3241_CR63","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3233\/JAD-2007-11411","volume":"11","author":"JT Coyle","year":"2007","unstructured":"Coyle JT, Geerts H, Sorra K, Amatniek J. Beyond in vitro data: a review of in vivo evidence regarding the allosteric potentiating effect of galantamine on nicotinic acetylcholine receptors in Alzheimer\u2019s neuropathology. J Alzheimer\u2019s Dis. 2007;11:491\u2013507.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"3241_CR64","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pbb.2020.173043","volume":"199","author":"B Hahn","year":"2020","unstructured":"Hahn B, Reneski CH, Lane M, Elmer GI, Pereira EFR. Evidence for positive allosteric modulation of cognitive-enhancing effects of nicotine by low-dose galantamine in rats. Pharmacol Biochem Behav. 2020;199:219\u201330.","journal-title":"Pharmacol Biochem Behav"},{"key":"3241_CR65","first-page":"486","volume":"53","author":"J Monbaliu","year":"2003","unstructured":"Monbaliu J, Verhaeghe T, Willems B, Bode W, Lavrijsen K, Meuldermans W. Pharmacokinetics of galantamine, a cholinesterase inhibitor, in several animal species. Arzneimittelforschung. 2003;53:486\u201395.","journal-title":"Arzneimittelforschung"},{"key":"3241_CR66","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1017\/S1461145710000222","volume":"13","author":"Y Noda","year":"2010","unstructured":"Noda Y, Mouri A, Ando Y, Waki Y, Yamada S-N, Yoshimi A, et al. Galantamine ameliorates the impairment of recognition memory in mice repeatedly treated with methamphetamine: involvement of allosteric potentiation of nicotinic acetylcholine receptors and dopaminergic-ERK1\/2 systems. Int J Neuropsychopharmacol. 2010;13:1343\u201354.","journal-title":"Int J Neuropsychopharmacol"},{"key":"3241_CR67","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/jphp.12919","volume":"70","author":"S Verma","year":"2018","unstructured":"Verma S, Kumar A, Tripathi T, Kumar A. Muscarinic and nicotinic acetylcholine receptor agonists: current scenario in Alzheimer\u2019s disease therapy. J Pharm Pharmacol. 2018;70:985\u201393.","journal-title":"J Pharm Pharmacol"},{"key":"3241_CR68","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1073\/pnas.081553598","volume":"98","author":"QS Liu","year":"2001","unstructured":"Liu QS, Kawai H, Berg DK. \u03b2-Amyloid peptide blocks the response of \u03b17-containing nicotinic receptors on hippocampal neurons. Proc Natl Acad Sci USA. 2001;98:4734\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3241_CR69","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2009.10.020","volume":"626","author":"R Epis","year":"2010","unstructured":"Epis R, Gardoni F, Marcello E, Genazzani A, Canonico PL, Di Luca M. Searching for new animal models of Alzheimer\u2032s disease. Eur J Pharmacol. 2010;626:57\u201363.","journal-title":"Eur J Pharmacol"},{"key":"3241_CR70","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.neurobiolaging.2016.06.005","volume":"46","author":"S Lombardo","year":"2016","unstructured":"Lombardo S, Catteau J, Besson M, Maskos U. A role for \u03b22* nicotinic receptors in a model of local amyloid pathology induced in dentate gyrus. Neurobiol Aging. 2016;46:221\u201334.","journal-title":"Neurobiol Aging"},{"key":"3241_CR71","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nrd2927","volume":"8","author":"A Taly","year":"2009","unstructured":"Taly A, Corringer P-J, Guedin D, Lestage P, Changeux J-P. Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system. Nat Rev Drug Discov. 2009;8:733\u201350.","journal-title":"Nat Rev Drug Discov"},{"key":"3241_CR72","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00018-020-03558-z","volume":"78","author":"MS Prevost","year":"2021","unstructured":"Prevost MS, Bouchenaki H, Barilone N, Gielen M, Corringer PJ. Concatemers to re-investigate the role of \u03b15 in \u03b14\u03b22 nicotinic receptors. Cell Mol Life Sci. 2021;78:1051\u201364.","journal-title":"Cell Mol Life Sci"},{"key":"3241_CR73","first-page":"e2220","volume":"96","author":"H Xu","year":"2021","unstructured":"Xu H, Garcia-Ptacek S, J\u00f6nsson L, Wimo A, Nordstr\u00f6m P, Eriksdotter M. Long-term effects of cholinesterase inhibitors on cognitive decline and mortality. Neurology. 2021;96:e2220\u2013e2230.","journal-title":"Neurology"},{"key":"3241_CR74","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1523\/JNEUROSCI.1732-07.2007","volume":"27","author":"N Wanaverbecq","year":"2007","unstructured":"Wanaverbecq N, Semyanov A, Pavlov I, Walker MC, Kullmann DM. Cholinergic axons modulate GABAergic signaling among hippocampal interneurons via postsynaptic alpha 7 nicotinic receptors. J Neurosci. 2007;27:5683\u201393.","journal-title":"J Neurosci"},{"key":"3241_CR75","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1126\/science.aay0198","volume":"365","author":"B Zott","year":"2019","unstructured":"Zott B, Simon MM, Hong W, Unger F, Chen-Engerer H-J, Frosch MP, et al. A vicious cycle of \u03b2 amyloid\u2013dependent neuronal hyperactivation. Science. 2019;365:559\u201365.","journal-title":"Science"},{"key":"3241_CR76","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1038\/s41380-019-0483-4","volume":"25","author":"S Hijazi","year":"2020","unstructured":"Hijazi S, Heistek TS, Scheltens P, Neumann U, Shimshek DR, Mansvelder HD, et al. Early restoration of parvalbumin interneuron activity prevents memory loss and network hyperexcitability in a mouse model of Alzheimer\u2019s disease. Mol Psychiatry. 2020;25:3380\u201398.","journal-title":"Mol Psychiatry"},{"key":"3241_CR77","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1113\/jphysiol.2011.220095","volume":"590","author":"M Griguoli","year":"2012","unstructured":"Griguoli M, Cherubini E. Regulation of hippocampal inhibitory circuits by nicotinic acetylcholine receptors. J Physiol. 2012;590:655\u201366.","journal-title":"J Physiol"},{"key":"3241_CR78","doi-asserted-by":"crossref","first-page":"9165","DOI":"10.1523\/JNEUROSCI.17-23-09165.1997","volume":"17","author":"A Orr-Urtreger","year":"1997","unstructured":"Orr-Urtreger A, G\u00f6ldner FM, Saeki M, Lorenzo I, Goldberg L, De Biasi M, et al. Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents. J Neurosci. 1997;17:9165\u201371.","journal-title":"J Neurosci"},{"key":"3241_CR79","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature03694","volume":"436","author":"U Maskos","year":"2005","unstructured":"Maskos U, Molles BE, Pons S, Besson M, Guiard BP, Guilloux JP, et al. Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature. 2005;436:103\u20137.","journal-title":"Nature"},{"key":"3241_CR80","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/mp.2013.158","volume":"19","author":"C Morel","year":"2014","unstructured":"Morel C, Fattore L, Pons S, Hay YA, Marti F, Lambolez B, et al. Nicotine consumption is regulated by a human polymorphism in dopamine neurons. Mol Psychiatry. 2014;19:930\u20136.","journal-title":"Mol Psychiatry"},{"key":"3241_CR81","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nn.3340","volume":"16","author":"C Schmidt-Hieber","year":"2013","unstructured":"Schmidt-Hieber C, H\u00e4usser M. Cellular mechanisms of spatial navigation in the medial entorhinal cortex. Nat Neurosci. 2013;16:325\u201331.","journal-title":"Nat Neurosci"},{"key":"3241_CR82","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00424-002-0831-z","volume":"444","author":"TW Margrie","year":"2002","unstructured":"Margrie TW, Brecht M, Sakmann B. In vivo, low-resistance, whole-cell recordings from neurons in the anaesthetized and awake mammalian brain. Pflug Arch. 2002;444:491\u20138.","journal-title":"Pflug Arch"},{"key":"3241_CR83","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/j.celrep.2016.05.026","volume":"15","author":"W-J Zhao","year":"2016","unstructured":"Zhao W-J, Kremkow J, Poulet JFA. Translaminar cortical membrane potential synchrony in behaving mice. Cell Rep. 2016;15:2387\u201399.","journal-title":"Cell Rep"},{"key":"3241_CR84","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/0896-6273(95)90181-7","volume":"15","author":"D Ulrich","year":"1995","unstructured":"Ulrich D, Huguenard JR. Purinergic inhibition of GABA and glutamate release in the thalamus: implications for thalamic network activity. Neuron. 1995;15:909\u201318.","journal-title":"Neuron"},{"key":"3241_CR85","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1101\/pdb.top081810","volume":"2014","author":"D Dombeck","year":"2014","unstructured":"Dombeck D, Tank D. Two-photon imaging of neural activity in awake mobile mice. Cold Spring Harb Protoc. 2014;2014:726\u201336.","journal-title":"Cold Spring Harb Protoc"},{"key":"3241_CR86","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41592-019-0470-3","volume":"16","author":"J Ho","year":"2019","unstructured":"Ho J, Tumkaya T, Aryal S, Choi H, Claridge-Chang A. Moving beyond P values: data analysis with estimation graphics. Nat Methods. 2019;16:565\u20136.","journal-title":"Nat Methods"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03241-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03241-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03241-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T10:03:10Z","timestamp":1771408990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03241-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":86,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["3241"],"URL":"https:\/\/doi.org\/10.1038\/s41380-025-03241-4","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,23]]},"assertion":[{"value":"31 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}